共 64 条
[1]
Tabish SA(2007)Is diabetes becoming the biggest epidemic of the twenty-first century? Int J Health Sci (Qassim) 1 V-VIII
[2]
Saeedi P(2019)Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas Diabetes Res Clin Pract 157 107843-149
[3]
Petersohn I(2014)Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res Clin Pract 103 137-134
[4]
Salpea P(2005)Diabetes mellitus and its treatment Int J Diabetes Metab 13 111-502
[5]
Guariguata L(2012)SGLT-2 inhibition in diabetes mellitus: rationale and clinical prospects Nat Rev Endocrinol 8 495-311
[6]
Whiting DR(2019)An update on the safety of SGLT-2 inhibitors Expert Opin Drug Saf 18 295-49
[7]
Hambleton I(2018)Cardiorenal outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME trials: a systematic review Rev Cardiovasc Med 19 41-1251
[8]
Bastaki A(2017)SGLT-2 inhibitors through the windows of EMPA-REG and CANVAS trials: a review Diabetes Ther 8 1245-803
[9]
Ferrannini E(2013)Data mining of the public version of the FDA adverse event reporting system Int J Med Sci 10 796-63
[10]
Solini A(2016)OpenVigil FDA–inspection of US American adverse drug events pharmacovigilance data and novel clinical applications PLoS ONE 11 e0157753-994